- UroToday Home
- Urologic Oncology
The Latest Research on CRPC with Bone Metastases
Recent Abstracts
-
Assessment of the viability and treatment response of bone metastases in patients with metastatic castration-resistant prostate cancer using choline PET/CT.CRPC w/ bone metastasesJune 14, 2021
-
Immunophenotyping Reveals Longitudinal Changes in Circulating Immune Cells During Radium-223 Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer.CRPC w/ bone metastasesJune 8, 2021
-
Perceptions around bone-modifying agent use in patients with bone metastases from breast and castration resistant prostate cancer: a patient survey.CRPC w/ bone metastasesMay 28, 2021
-
Clinical outcomes, management, and treatment patterns in patients with metastatic castration-resistant prostate cancer treated with radium-223 in community compared to academic settings.CRPC w/ bone metastasesMay 14, 2021
-
Fracture Risk in Men with Metastatic Prostate Cancer Treated With Radium-223.CRPC w/ bone metastasesMay 9, 2021
-
Whole-Body [18F]-Fluoride PET SUV Imaging to Monitor Response to Dasatinib Therapy in Castration-Resistant Prostate Cancer Bone Metastases: Secondary Results from ACRIN 6687.CRPC w/ bone metastasesMay 5, 2021
-
Cancer Treatment-Induced Bone Loss in Hormone-Sensitive Cancer: The Paradigm of Cancer Survivor Bone Health Management.CRPC w/ bone metastasesMay 5, 2021
-
Improved Radium-223 Therapy with Combination Epithelial Sodium Channel Blockade.CRPC w/ bone metastasesApril 12, 2021
-
Kinetics of Radium-223 and its effects on survival, proliferation and DNA damage in lymph-node and bone metastatic prostate cancer cell lines.CRPC w/ bone metastasesMarch 30, 2021
-
Radium 223 treatment increase immune checkpoint expression in extracellular vesicles from the metastatic prostate cancer bone microenvironment.CRPC w/ bone metastasesMarch 26, 2021
Beyond the Abstracts
-
Bone Targeted Therapy and Skeletal Related Events in the Era of Enzalutamide and Abiraterone Acetate for Castration Resistant Prostate Cancer with Bone Metastases - Beyond the AbstractCRPC w/ bone metastasesOctober 27, 2020
-
Radium-223-Dichloride in Castration Resistant Metastatic Prostate Cancer-Preliminary Results of the Response Evaluation Using F-18-Fluoride PET/CT: Beyond the AbstractCRPC w/ bone metastasesApril 7, 2017
-
Prostate Cancer Cure is Possible: Beyond the AbstractCRPC w/ bone metastasesJanuary 5, 2017
-
The use of radium 223 dichloride in a multidisciplinary approach for treating metastatic castration-resistant prostate cancer, "Beyond the Abstract," by Elisa BorsòCRPC w/ bone metastasesFebruary 11, 2015